SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021096
Filing Date
2024-02-27
Accepted
2024-02-27 16:05:52
Documents
112
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rckt-20231231.htm   iXBRL 10-K 3130719
2 EX-10.13 rckt-ex10_13.htm EX-10.13 121671
3 EX-10.23 rckt-ex10_23.htm EX-10.23 19510
4 EX-21.1 rckt-ex21_1.htm EX-21.1 13971
5 EX-23.1 rckt-ex23_1.htm EX-23.1 4607
6 EX-31.1 rckt-ex31_1.htm EX-31.1 12920
7 EX-31.2 rckt-ex31_2.htm EX-31.2 13006
8 EX-32.1 rckt-ex32_1.htm EX-32.1 12124
9 EX-97 rckt-ex97.htm EX-97 50605
10 GRAPHIC img172964561_0.jpg GRAPHIC 115121
11 GRAPHIC img172964561_1.jpg GRAPHIC 46831
12 GRAPHIC img172964561_2.jpg GRAPHIC 160639
  Complete submission text file 0000950170-24-021096.txt   14276102

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rckt-20231231.xsd EX-101.SCH 1948200
114 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20231231_htm.xml XML 2441232
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36829 | Film No.: 24686517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)